Overview

A Sleep Laboratory Study to Investigate the Safety and Efficacy of the Rotigotine Skin Patch in Subjects With Restless Legs Syndrome and End-Stage Renal Disease Requiring Hemodialysis

Status:
Completed

Trial end date:
2013-10-01

Target enrollment:

Participant gender:

Summary

This is a sleep laboratory study to evaluate the efficacy and safety of Rotigotine in subjects with Restless Legs Syndrome and End-Stage Renal Disease requiring hemodialysis. The objectives are to demonstrate superiority of Rotigotine against Placebo as well as to investigate the effect of Rotigotine on quality of life and sleep.

Phase:

Phase 3

Details

Lead Sponsor:

UCB BIOSCIENCES GmbH

Treatments:

N 0437
Rotigotine